Closed CDC-RFA-PS-25-0003 CFDA 93.116 Discretionary

Tuberculosis Elimination and Laboratory Cooperative Agreement

Posted by Centers for Disease Control - NCHHSTP

Opportunity snapshot. This Grants.gov announcement — Tuberculosis Elimination and Laboratory Cooperative Agreement — is cataloged under number CDC-RFA-PS-25-0003 and tied to CFDA assistance listing 93.116, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on July 1, 2024 and last updated on September 27, 2024. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Varies by applicant. The agency has projected $374.5 million in total estimated funding for this announcement. It expects to issue 57 awards. If the agency funds the expected 57 awards from the $374.5 million estimated pool, the average award works out to roughly $6.6 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on October 4, 2024. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Varies by applicant

Close Date

October 4, 2024

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

July 1, 2024

Est. Total Funding

$374,456,055

Expected Awards

57

Instrument

Cooperative Agreement

Description

CDC announces available Fiscal Year (FY) 2025 funds to complement tuberculosis (TB) prevention and control activities and laboratory services at state and local levels to reduce TB morbidity and mortality. The goal of this funding is to prevent transmission of M. tuberculosis (TB) and prevent progression from latent TB infection to active TB disease. Funding levels are determined by formulas reflecting TB disease incidence, case complexity, program performance, and laboratory workload data. Strategies and activities include diagnosis/treatment of persons with TB disease and persons with latent TB infection (LTBI); examination of immigrants and refugees who have an overseas B classification for TB; targeted testing for, and treatment of, LTBI; program planning, evaluation, and improvement; epidemiologic surveillance and response; human resource development and partnership activities; and public health laboratory strengthening. Expected outcomes include (but are not limited to) decreases in TB incidence; increases in patients completing treatment within 12 months; increases in HIV and drug susceptibility testing in TB cases; increases in LTBI testing and treatment completion rates of those recommended for treatment; increases in accuracy and completeness of surveillance, genotyping, and whole-genome sequencing data; improvement in turnaround times for specimen receipt and laboratory testing and implementation of TB elimination plans.

Eligibility

00;01;02;25;99

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Martha Boisseau<br/>mboisseau@cdc.gov

Key Dates

Posted July 1, 2024
Close Date October 4, 2024
Archive Date November 3, 2024
Last Updated September 27, 2024

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Tuberculosis Elimination and Laboratory Cooperative Agreement", offered by Centers for Disease Control - NCHHSTP. It is associated with CFDA program 93.116. CDC announces available Fiscal Year (FY) 2025 funds to complement tuberculosis (TB) prevention and control activities and laboratory services at state and local levels to reduce TB morbidity and morta...
Is this opportunity still open?
No, this opportunity is closed. It closed on October 4, 2024. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $374,456,055. Expected number of awards: 57.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial